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Abstract  
Background: At a primary care center in Brooklyn, New York, approximately 27% of 
diabetic patients with abnormal Hgb A1C fail to return for follow-up appointments, as 
recommended by the Centers for Disease Control and Prevention (CDC). According to 
electronic medical records (EMR), healthcare providers demonstrated inconsistency in 
ordering and monitoring Hgb A1C and clinic follow-up appointments for patients.   
Purpose:  The purpose of this quality improvement project was to determine 
retrospectively the healthcare providers’ ordering, monitoring, and follow-up 
appointments for adult diabetic patients with abnormal Hgb A1Cs; to develop and 
implement a standardized process for healthcare providers to monitor and follow these 
patients, especially those with possible nonclinic follow-up compliance and abnormal 
Hgb A1C; to determine prospectively healthcare providers’ ordering, monitoring, and 
follow-up appointments; and to evaluate the prospective charts to determine if Hgb AIC 
results changed from abnormal to normal or elevation over time until the next follow-up 
appointment.    
Theoretical Framework: The theoretical framework was the nursing practice model, 
which allows clinical systems to redesign operational processes associated with patient 
care for innovative clinical advancement outcomes.  
Methods: Frequency tests were used to determine appointment adherence retrospectively 
and prospectively, with a convenience sample of seven healthcare providers and review 
of 99 retrospective and prospective medical records of diabetic patients who met 
inclusion criteria. A nonparametric quantitative paired t test was used to measure patients 
diagnosed with poorly controlled diabetes who were treated over two 3-month timespans.  
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Results: The difference in A1C scores between the two 3-month periods ranged from 4.5 
to 2, with an average improvement of -1.32. These scores reflected an improvement in 
healthcare providers’ ordering and monitoring of Hgb A1C after CDC-implemented 
standardized guideline and recommendations.  
Conclusion:  The lack of appropriate healthcare provider management of diabetic 
patients can lead to additional health complications.  Monitoring of patients’ Hgb A1C 
levels through prospective electronic medical record reviews is a simple yet viable 
approach. With this approach, healthcare practitioners can improve ordering and 
monitoring of Hgb A1C for normalcy and follow-up consistency after implementation of 
standardized practice.  
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Managing Diabetic A1c at A Primary Care Center:   
A Nurse Practitioner Perspective 
Chapter 1 
 Nature of Project and Problem Identification  
Diabetes rates in the United States (U.S.) have risen to epidemic proportions.  In 
2015, approximately 30.3 million people of all ages, nearly 10% of the population, were 
diagnosed for diabetes. In the same year, 33.9% of U.S. adults aged 18 years or older 
(84.1 million people) had prediabetes (Centers for Disease Control and Prevention 
[CDC], 2017).  Diabetes affects individuals of all ages, but it is most prevalent among 
those 65 years and older (American Diabetes Association [ADA], 2016).  It has been 
predicted that by 2050, diabetes will affect as many as one in three American adults.    
In 2010, diabetes was identified as the seventh leading cause of death but, as 
diabetes leads to several severe comorbidities, it is listed as a contributing cause of death 
to many more.  Comorbidities that frequently coexist with diabetes include hypertension, 
dyslipidemia, nonalcoholic fatty liver disease, cardiovascular disease, kidney disease, and 
obesity (Centers for Disease Control and Prevention [CDC], 2011).  The disease process 
of diabetes damages blood vessels of all types and the organs to which blood flows.  
People who have diabetes are at a higher risk than nondiabetics for developing infections, 
cardiovascular disease, kidney failure, lower-limb amputation, and blindness.  Other 
conditions such as nerve damage, damage to teeth and gums, and sexual dysfunction are 
additional comorbidities that result from diabetes 
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(International Diabetes Federation, 2017; National Institute of Diabetes and Digestive 
and Kidney Diseases (NIDDK, 2014).   
For diabetics, lack of proper monitoring of blood glucose levels leads not only to 
the diseases and conditions listed above, but also lack of proper blood glucose level 
monitoring can be fatal due to coma or hard-to-treat infections (National Institute of 
Diabetes and Digestive and Kidney Diseases [NIDDK], 2017).  The importance of 
monitoring blood glucose levels makes it imperative that blood not only be monitored 
daily but also should also be monitored based on how glucose is metabolized over a 
period of time.  The incidence of complications of diabetes can be reduced through 
careful management directed at maintaining glycemic control in adult, non-gestational 
individuals with type 2 diabetes at a target Hgb A1C level of less than 7% (American 
Diabetes Association [ADA], 2014).  This target level can be achieved with Hgb A1C 
testing, which can be enhanced through the use of a systematic/team approach.   
Diabetes management requires the cooperative activities of an interprofessional 
healthcare team.  Diabetes is a chronic disease that is increasing locally and globally and 
is a leading cause of disability.  Diabetes is costly to society in terms of dollars and 
human suffering (American Diabetes Association [ADA], 2013).  The ill effects of 
diabetes can be largely reduced through consistent monitoring of Hgb A1C and the 
timely implementation of interventions to reduce the Hgb A1C among patients whose 
diabetes is poorly controlled.   
Currently there is a lack of standardization in ordering Hgb A1C testing for 
diabetic management in a primary care center in Brooklyn, New York.  As a result, 
patients do not receive timely modification of their treatment plans, the Hgb A1C 
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continues to be in the unacceptable range, and patients frequently suffer serious adverse 
consequences. 
The investigator is a family nurse practitioner at this primary care center, in which 
healthcare providers serve a large population of Caribbean Americans at risk for various 
chronic diseases, especially diabetes.  A challenge is evident with care continuity among 
these patients.  The care of approximately 500 of these patients is undertaken by the 
family nurse practitioners (FNP) who partner with medical providers (i.e., medical 
doctors [MDs]).  Of those patients seen and cared for at the clinic, 80% are diagnosed 
with type 2 diabetes mellitus (T2DM), and approximately 75% of these patients 
diagnostically have unacceptable Hgb A1C or fasting blood glucose levels.  Some of 
these patients are 50 years old, but in many cases they have developed diabetic 
neuropathy, which is found in higher prevalence in the elderly population (Cleveland 
Clinic, 2018).  Furthermore, 60% of these patients (300) suffer from other comorbidities, 
including hypertension and high blood cholesterol levels.   
In spite of diabetes and comorbidities, a portion of the patients do not adhere 
consistently to clinic follow-up appointments, and they sporadically cancel scheduled 
appointments.  The gap associated with care inconsistency stems from missed follow-up 
appointments and the lack of required Hgb A1C testing, as recommended by the Centers 
for Disease Control and Prevention (CDC, [2016]) for standardization of healthcare 
providers’ practice and patient outcomes.  The gap revealed through providers’ 
documentation in electronic medical records (EMR) that some patients’ Hgb A1C tests 
were missed or inconsistently ordered, contrary to recommendations by the CDC (2016).   
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Problem Statement 
 Approximately 27% of patients with an abnormal Hgb A1C at a primary care 
center in Brooklyn, New York, fail to return for follow-up appointments within the 
recommended CDC 3-month period.  
Purpose Statement  
The purpose of this quality improvement project was to determine retrospectively 
the healthcare providers’ ordering, monitoring, and follow-up appointments for adult 
diabetic patients with abnormal Hgb A1Cs; to develop and implement a standardized 
process for healthcare providers to monitor and follow these patients, especially those 
with possible nonclinic follow-up compliance and abnormal Hgb A1C; to determine 
prospectively healthcare providers’ ordering, monitoring, and follow-up appointments; 
and to evaluate the prospective charts to determine if Hgb AIC results changed from 
abnormal to normal or elevation over time until the next follow-up appointment.    
Project Objectives 
The following were the objectives for this project: 
1. Conduct a retrospective electronic medical record review of adult diabetic 
patients with abnormal Hgb A1Cs who failed to return for follow-up 
appointments between March 1 and May 31, 2017, at Week 1 after IRB 
approval.  
2. Develop and implement a standardized process for healthcare providers to 
closely monitor and follow adult diabetic patients, especially those with 
possible nonclinic follow-up-compliance and abnormal Hgb A1C at Week 3.  
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3. Conduct a prospective electronic medical record review of the same Hgb A1C 
abnormal adult diabetic patients as the retrospective review.  These patients 
attended follow-up appointments between June 1 and August 31, 2017, at Week 
12. 
4. Evaluate the EMR charts prospectively to determine if the diabetic patients’ Hgb 
AIC results in changes from abnormal to normal or elevation over time until the 
next follow-up appointment at Week 16.    
Theoretical Framework 
 The theoretical framework used for this project was the nursing practice model. 
This model allows clinical systems to redesign their operational processes associated with 
patient care for innovative clinical advancement outcomes. 
Practice Model  
A quality improvement guide (QI) published by the United States Department of 
Health and Human Services, Health Resources and Services Administration (USHRSA, 
2011) was used for standardized nursing services at the patient care and nursing unit 
levels for organizational best outcomes. USHRSA (2011) defined the QI as “systematic 
and continuous actions that lead to measurable improvements in healthcare services and 
the health status of targeted patients” (p. 1).  The QI guide assists organizations in using 
systems and processes that focus on patients, team building, and data analysis before and 
after changes. The model illustrates the outcomes of nursing service, practice, 
collaboration, communication, and professional development as related to patient-family- 
centered care.  
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As outlined in Figure 1, the model’s principles frame the system approach used 
for this project.  The QI guide describes the systems, processes, and resources which will 
be used; the activities or processes which will be carried out; and the projected results or 
inputs processes and outputs.   
Inputs  
 
 
 
 
 
 
 
Activities 
 (Processes) 
 
Inputs  
 
 
 
  
 
 
 
 
 
Outputs  
 
Outputs  
 
 
Figure 1.  Inputs, processes, and outputs/outcomes. Adapted from USHRSA (2011), p. 2. 
The Hgb A1C test is considered a safe and effective mechanism for testing blood 
glucose levels.  According to the USHRSA (2011), “Hgb A1C testing is a well-
established strategy to monitor glycemic control in patients with diabetes” (p. 3).  The 
program will take advantage of this strategy. 
According to the model, there is interdependency between the Inputs, 
Activities/Processes, and Outputs in the system design of the program.  All Input 
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control. This is a part of the Activities/Processes component of the model.  Once 
educated on the importance of Hgb A1C percentage for effective diabetes management, 
all Input stakeholders will apply the system appropriately for monitoring.  This 
application should have a major effect on the Outputs of the project.   
The USHRSA (2011) explanation applies to this project:  
 
Activities or processes within a healthcare organization contain two major 
components: 1) what is done (what care is provided), and 2) how it is done (when, 
where and by whom care is delivered) . . . the greatest impact for QI is when both 
are addressed at the same time.  (p. 3) 
 
Education to healthcare providers about the need for and use of Hgb A1C testing for 
monitoring are disseminated to the healthcare team as well as the patients, for 
inclusiveness and collaboration.  Patients and healthcare providers are now a team. 
Focus on patients.  Effective QI programs must focus on patients.  Proper focus 
on patients comprises three major aspects. The first is providing interventions which are 
safe and evidenced-based.  The second is that delivery of the program must be culturally 
competent, linguistically relevant, literate appropriate, and supportive for patient 
engagement (USHRSA, 2011).  The third is that focus on patient programs also connects 
patients to other providers, as needed.   
 The QI program developed for this project included these elements in its design 
through the use of materials targeted to the needs of the population served relating to 
culture, language, and literacy levels.  The support for patient engagement is inherent in 
the process because of the need for constant communication between providers and 
patients for the program to be maximally effective.  
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Interventions to improve Hgb A1C levels, as examples of healthcare providers 
connecting patients to other providers, may also include the use of exercise therapists and 
dieticians or nutritionists as needed, based on patients’ Hgb A1C levels.   
Focus on being part of the team.  The institutional use of teamwork is becoming 
more prevalent in all work environments (Mitchell et al., 2012, “Importance of 
interprofessional collaboration in healthcare,” 2017).  For healthcare providers to focus 
on being part of the team means understanding the need for different perspectives and 
respecting the contributions of all team members.  Teams are most effective when the 
process or system involved is complex, when solutions require creativity, when more 
than one person in the organization knows all the aspects of an issue, when the process 
involves more than one discipline, and when staff loyalty and buy-in are needed 
(USHRSA, 2011) and when the team adheres to standardized practice (CDC, 2016).   
 The elements of effective teams have been supported by research studies.  In a 
literature review conducted by Lakhani, Benzies, and Hayden (2012) to examine the 
attributes essential for effective functioning of interdisciplinary teams, the researchers 
identified seven attributes; “team purpose, goals, leadership, communication, cohesion, 
mutual respect and reflection” (p. E260).  The current project employed these 
characteristics in the program design in the following ways: 
Team purpose.   Effective teams have a well-defined team purpose that is 
progressive and well-defined (Lakhani et al., 2012).  The mission statements of most 
healthcare organizations focus on a purpose statement that indicates progressiveness and 
well-defined consensus.  These qualities lend support to the different activities of various 
teams and their purposes.  The purpose for the team working on this project was to order 
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Hgb A1C, monitor results, and monitor follow-up appointments to improve outcomes for 
patients with diabetes and to standardize providers’ practice in accordance with 
recommendations of the CDC (2016).   
Goal.  The primary goal was to standardize providers’ practice in relation to 
diagnostic ordering, monitoring, and follow-up appointment consistency to obtain 
diabetic patients’ Hgb A1C normalcy and clinic follow-up adherence.  
 Leadership.  According to Lakhani et al. (2012), the leadership style for a 
program should be democratic to encourage collaboration as a valued attribute: 
“successful teams generally have a stable core” (p. E262).  The leadership for this DNP 
project was nurse-driven (i.e., family nurse practitioner) with a collaborative 
intraprofessional team of experts in diabetic management. The nurse-driven leadership 
provided feedback, education, progress reports, coaching, and mentoring for providers 
caring for the diabetic population affiliated with the project.   
Communication.  The intraprofessional team was introduced to the 
communication system that guided this DNP project.  To maintain continuous 
communication among all team members (FNPs, RNs, MDs, administration, and other 
healthcare providers), biweekly QI meetings were held.  The communication was 
provided through various methods (emails, individual and/or group meetings, 
GoToMeeting conferences), which often required smaller ad hoc committee meetings. 
Figure 2 illustrates the nurse-driven (FNP) communication process, in accordance with 
the theoretical framework. 
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Theory Support 
As outlined in Figure 2, a two-way communication system had previously existed 
between nurses (RNs), doctors (MDs), administration, and other team members.  The 
nurse-driven leader (FNP) was responsible for providing continuous updates to the 
intraprofessional team on the quality improvement/DNP project status, in addition to 
implementing all team recommendations and modifications for project success.  The 
institution’s administration provided direct contact and needed resources for the project 
to meet the CDC (2016) standardized recommendations for adherence to diabetic practice 
and management.   
Finally, the RNs networked with various referral services (i.e., other team 
members) to provide a foundation for providers to order and monitor the required 
services in accordance with regulatory standards.  These procedures complied with the 
observation of Lakhani et al. (2012): “Exchanging information and ideas allows team 
members to share their expertise with one another” (p. E262). The leader of this quality 
improvement/DNP project strived to be consistent in these areas of communication and 
collaboration.   
Cohesion.  Meetings and retreats were two procedures inherent in this theoretical 
framework, and thus biweekly meetings (ad hoc and/or monthly intraprofessional) and 
one brainstorming retreat were implemented.  The cohesion achieved from these 
meetings allowed the project team and work to progress at an all-time high. Suggestions 
and ideas were continuous, especially throughout project implementation.  The continued 
eliciting of input from members of the group through suggestion boxes, ad hoc committee 
meetings, mini-assessments, and other means demonstrated that all team members agreed 
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with the project objectives and their importance and were satisfied with implementing 
practice change for diabetic patient management.   
 
 
 
 
 
 
Figure 2.  Communication network (investigator-designed). 
 
Mutual respect.  The DNP project team demonstrated mutual respect for each 
professional level of expertise, in accordance with the theoretical model. The team’s 
respect denoted, according to the theoretical framework, the receptiveness or openness to 
the differences in skills, knowledge, talents, and beliefs in addition to recognition of the 
value of each member’s input (Lakhani et al., 2012).  The team decided at the onset that 
no tolerance would be given to disrespect, such as name calling, degrading, back-talking, 
rank-and-file authority, use of profanity, harassment, and other similar forms of behavior. 
Reflection.  The project team first discussed professional borders and 
acknowledged that various professional insights can prohibit the project’s progression if 
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to Lakhani et al (2012), the individual or team must consider that “reflection ranges from 
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thinking of an event to increased awareness of feelings, values and actions, for 
considering various solutions for a problem” (p. E263).  It was imperative that the project 
team saw this project as an opportunity to enhance both patient outcomes and providers’ 
increased knowledge and implementation of standardized practice through ordering and 
monitoring diabetic patients’ Hgb A1C consistently for maintaining care continuity.    
Focus on the use of data.  The outcome of this DNP project demonstrated the 
need for diabetic Hgb AIC clinical practice modification and standardization by 
providers.  The data provided an overview of how clinical processes at the primary care 
center worked or did not work, the need for change, and the changes that were were 
needed in order to meet the CDC’s (2016) recommendations for diabetic management 
and practice standardization.   In addition, the data revealed what was thought to be true 
existing clinical practice, established a baseline for knowledge enhancement, provided a 
vehicle for monitoring care continuity challenges, and provided a vehicle for measuring 
and comparing retrospective and prospective Hgb A1C performances to indicate what 
changes were working.  The data also revealed, as USHRSA (2011), noted, which 
changes “Reduce[d]s the placement of ineffective solutions” (p. 4).   
Project Significance 
Nursing Practice 
This project impacted how providers practice nursing.  Through the 
implementation of new strategies and standards, providers successfully managed patients’ 
Hgb A1C results and clinical follow-up appointment adherence at a primary care center 
in Brooklyn, New York. The project findings established the foundation for healthcare 
practitioners to standardize diabetic Hgb A1C management using the CDC (2016) 
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recommendations’ in addition to incorporating evidence-based practice (EBP) to 
maintain care consistency in clinical practice.  
In 2012, it was estimated that individuals diagnosed with diabetes cost $245 
billion in direct medical costs and reduced work productivity among the working class. 
According to ADA (2013), calculation per patient with diabetes showed approximately 
$13,700 each year, which was 2.3 times higher than the amount spent for persons without 
diabetes.  Through appropriate provider management, healthcare institutions’ costs can be 
reduced through standardizing patient care and diagnostic monitoring and follow-up 
consistency.  Nursing practitioners, especially APRNs, can serve as the first supporters of 
care continuity, as defined in the Institute of Medicine (IOM, 2014) annual report, 
through care standardization, ordering, and monitoring to eradicate diabetic care 
inconsistency and promote clinic follow-up adherence.  These actions apply to the clinic 
at which this project was conducted.     
Healthcare Outcomes 
Diabetes management can be enhanced through standardized practice associated 
with appropriate regulatory requirements and recommendations.  Healthcare providers 
who adhere to standardized practice increase patient healthcare outcomes (i.e., Hgb 
A1C), in addition to increasing health practice outcomes. At the primary care center 
where this DNP project was conducted, the lack of standardized healthcare outcomes was 
discovered by the project investigator through a retrospective review of diabetic patients’ 
EMR.  The lack of or insufficient ordering of Hgb A1C required by CDC (2016) 
recommendations and the inconsistency in scheduled follow-up appointment adherence 
among persons diagnosed with diabetes produced poor health outcomes and care 
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management irregularities. With changes in clinical practice, enhanced standardization, 
ordering, and monitoring of Hgb A1C at the center, patients’ diagnostic outcomes 
according to a prospective electronic medical record (EMR) revealed an increase in 
health outcomes.   
Healthcare Delivery   
The healthcare delivery processes used for this project was extensive. The 
processes expanded the existing practice to incorporate the CDC (2016) standardized 
recommendations for consistent Hgb A1C ordering and technological monitoring for 
diabetic patient management by healthcare providers. The prospective EMR revealed that 
patients with elevated Hgb A1C levels who adhered to follow-up appointments and 
proper healthcare provider diagnostic monitoring demonstrated reliable outcomes 
throughout the delivery processes.  The changes in healthcare delivery resulting from the 
components of the project enhanced interdisciplinary communication and relationships 
and promoted providers’ and patients’ active participation in clinical care.   
Healthcare Policy   
Healthcare policies are a changing paradigm that evolves as patient care needs 
evolve (Sepucha, Fowler, & Mulley, 2004).  Those healthcare policies that prevent, 
restore, or maintain care for all healthcare arenas, especially chronic conditions such as 
diabetes, influences healthcare delivery, outcomes, and practice.  The results of this 
project revealed that changes in existing Hgb A1C levels by integration of CDC 
standards and follow-up appointment consistency changed patients’ and practice 
outcomes system wide.   
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Implementation of the practice changes can apply globally to other clinics and can 
reduce healthcare costs of standardize care and improve patient outcomes, particularly in 
diabetes, one of the most preventable health conditions (Harvard T. H. Chan School of 
Public Health, 2018).  This DNP project demonstrated the significance of improvement 
of patients’ Hgb A1C management through enhanced provider care standardization, 
monitoring, and follow-up appointment consistency.  
Summary 
Standardized practice, monitoring, and follow-up appointments are essential for 
care management of diabetic patients at a primary care center in Brooklyn, New York. 
This DNP project utilized technology (EMR) to identify gaps in care continuity and 
diagnostic monitoring inconsistency in practice.  The healthcare providers’ orders and 
monitoring of patients’ diabetes mellitus Hgb A1C require incorporation of standardized 
ordering and monitoring of Hgb A1C and reduction of inconsistent follow-up 
appointments. These changes are paramount for positive practice outcome and care 
continuity.  Over the past two decades, literature has shown that consistent Hgb A1C 
ordering and monitoring by providers is an essential procedure for diabetes management. 
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Chapter 2 
Review of the Literature 
The purpose of this quality improvement project at a primary care clinic in 
Brooklyn, New York, was to determine retrospectively the healthcare providers’ 
ordering, monitoring, and follow-up appointments for adult diabetic patients with 
abnormal Hgb A1Cs; to develop and implement a standardized process for healthcare 
providers to monitor and follow these patients, especially those with possible nonclinic 
follow-up compliance and abnormal Hgb A1C; to determine prospectively healthcare 
providers’ ordering, monitoring, and follow-up appointments; and to evaluate the 
prospective charts to determine if Hgb AIC results changed from abnormal to normal or 
elevation over time until the next follow-up appointment.  For this project, several search 
strategies were used with a number of databases.  
Search Strategies 
A literature search was conducted using the following databases: Academic 
Search Premier, CINAHL-Complete, Cochrane Database of Systematic Literature 
Reviews, Health Technology Assessments, Medline, and Nursing and Allied Health 
Collections: Comprehensive.  For search options, Boolean/Phrase, Apply Related Words, 
and Also Search within Full-Text of articles were set for Search Modes and Expanders.  
The type and year parameters were scholarly peer-reviewed journals and January 2009 
through December 2016, as well as English language only.  Additional 
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sources of information were obtained from government reports and articles with the use 
of Google and Google Scholar and the Joanna Briggs Institute database.  
With these databases and settings, the following keywords were used alone and in 
various combinations: A1C monitoring, A1C testing, blood glucose, diabetes guidelines, 
improved, intervention, management, nurses, nursing, patient outcomes, and type 2 
diabetes.  All of these words are pertinent to the use of Hgb A1C as an assessment of 
blood glucose levels and the relationship of these levels to successful diabetes 
management.  The overreaching themes identified in the literature were related to Hgb 
A1C testing, Hgb A1C monitoring, point of care interventions, self-management of 
diabetes, nurse-led interventions, hyperglycemic control, the effects of health education, 
and management of diabetes.   
Hgb A1C Testing 
Knowledge of patients’ glycemic status as an essential component for diabetes 
care and management is acknowledged by healthcare practitioners worldwide (Holt, 
2014; NIDDK, 2014; Perrota et al., 2014).  In addition, monitoring of blood glucose 
levels is useful for diagnosing diabetes and prediabetes (ADA, 2014; Holt, 2014; 
NIDDK, 2014).  The importance of testing blood glucose levels using the A1C test is 
related to the fact that in many cases damage is already present in the microvascular and 
macrovascular systems due to high blood sugar levels prior to diabetes diagnosis (Holt, 
2014; Perrota et al., 2014).   
Other forms of glucose testing cannot determine the long-term measurements of 
blood sugar levels as comprehensively as A1C testing (ADA, 2014; Holt, 2014; Jones, 
2013; Zhou et al., 2010).  Therefore, Hgb A1C testing is an essential approach for 
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improving nursing and healthcare delivery and results.  Hgb A1C is an applicable 
diagnostic test for prediabetes and diabetes in adults (Jones, 2013).  The usual course of 
aging comes with a higher rate of A1C; that is, aging is generally associated with 
increases in A1C levels, although diabetes can develop at any age (ADA, 2016). 
Therefore, there are significant disparities may take place between Hgb A1C-based 
diagnosis and fasting plasma glucose based in adults, a discrepancy influenced by gender 
and race (Meneilly, Knip, & Tessier, 2013).  Hence, Hgb A1C testing at earlier ages in 
vulnerable populations may decrease the development of diabetes.  
Hgb A1C Monitoring 
 Despite the effectiveness and recommendation for Hgb A1C testing for diabetes 
management by the ADA and others, no mandate exists at present for its use.  According 
to the NIDDK (2014), Hgb A1C monitoring can be used to assess the blood glucose 
levels of patients with diabetes (both types 1 and 2), and information gained can be used 
for adjusting medications, as well as reduction of risks of lifelong complications.  
Because of the comprehensive ability of Hgb A1C testing to measure blood glucose 
levels in the long term, over the life of red blood cells (120 days), it is considered the 
“gold standard” and recommended for use in the management of diabetes (Holt, 2014; 
Perrota et al., 2014).   
Point-of-Care Testing Intervention and Hgb A1C 
 According to the National Institutes of Health (NIH, 2013), point-of-care testing 
(POCT) “allows patient diagnoses in the physician’s office, an ambulance, the home, the 
field, or in the hospital” (p. 1).  With POCT, early diagnosis and treatment decisions can 
be made rapidly with the latest in information on patient status (Jones, 2013).  NIH 
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(2013) considered POCT as a tool of empowerment for healthcare practitioners, not only 
as an enhancement of the ability to make time-sensitive decisions but also as a tool to 
limit health disparities.   
POCT can provide pertinent diagnostic information in one session, a quality vital 
to diabetes management (Jones, 2013).  Good glycemic control is indicated by a Hgb 
A1C value between 6.5% and 7.5% (48-58 mmol/mol), with the nondiabetic reference 
range 4.0%-6.0% (20-42 mmol/mol), providing the patients has no disabling 
hypoglycemic condition.  The case for using Hgb A1C monitoring as a POCT strategy 
for managing diabetes is strengthened because patients can take action immediately on 
the results of this test, which also increases patient satisfaction (Yang et al., 2016).  Jones 
(2013) conducted four observational studies involving more than 5,700 patients with 
diabetes, where immediate feedback of their Hgb A1C status was provided. Jones (2013) 
found significant reductions in Hgb A1C levels, with one patient maintaining appropriate 
A1C status for more than 4 years  
According to Meetoo and Wong (2015), use of the Hbg A1C test for diabetes 
management is also fiscally sound.  According to the results of studies conducted by 
Snellman and Eckerborn (1997) and Pluddemann, Heneghan, Price, Wolstenholme, and 
Thompson (2011), the benefits of implementing Hgb A1C testing at home were fewer 
clinic visits, reduction in labor costs and travel time, and overall reduction in the costs of 
diabetes management.  As in the study by Jones (2013), Meeto and Wong (2015) found 
that use of the Hgb A1C test for monitoring of blood glucose levels also increased 
customer satisfaction and better adherence to treatment regimens.  Both Jones (2013) and 
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Meetoo and Wong (2015) stressed administration of a Hgb A1C test every 3 months as 
essential for effective monitoring of diabetic patients as part of a POCT intervention. 
Self-Management and Knowledge of Hgb A1C Test 
Self-management of any disease is generally enhanced when patients understand 
the reasons why they should engage in a treatment or a test (Meetoo & Wong, 2015).  For 
patients, management of a chronic disease requires knowledge, discipline, and 
encouragement from a team of professionals.  Patients’ knowledge of why they should 
engage in a test and the meaning of a test has been studied in relationship to self-care 
levels and knowledge of a disease and how it affects patient health. 
Heisler, Piette, Spencer, Kieffer, and Vijan (2005) conducted a cross-sectional 
survey with a sample of 686 U.S. adults diagnosed with type 2 diabetes in five health 
systems.  The hypothesis was that knowledge of their actual and target health outcomes 
(such as Hbg A1C values) was a prerequisite for effective patient involvement in 
management of chronic diabetes.  The patients had checked in 6 months before the study 
and their Hbg AlC levels recorded.  
Based on multivariate analysis, which analyzed patient characteristics, healthcare 
provider communication, and health system type, the results of the study showed that 
66% of the respondents did not know their last Hbg A1C values, and 25% were able to 
accurately report their values.  Respondents who did know their last Hbg A1C values 
were better able to accurately assess their diabetes control.  Higher evaluations of 
provider communication ability were independently associated with knowledge of Hbg 
A1C.  However, knowledge of Hbg A1C had no effect on self-efficacy or reported self-
management behaviors in this study (Heisler et al., 2005).  
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Additional studies on knowledge of the meaning of Hgb A1C and the importance 
of knowledge of laboratory test with regard to self-care and successful glycemic control 
have also been conducted in other countries.  In a cross-sectional survey conducted at 50 
medical centers in various locations in China, researchers proposed that Hgb A1C 
knowledge is a prerequisite for effective self-management. Participants were asked “How 
long does A1c reflect average blood glucose level?” and “What is the recommended A1C 
level by Chinese Diabetes Society guideline?” (Yang et al., 2016, p. 4).  
A higher quantity of patients with well-controlled diabetes was identified as 
having a “good understanding” of Hgb A1C (Yang et al., 2016, p. 9).  In addition, 
patients in the “good understanding” group were more likely to perform self-monitoring 
of blood glucose than those in the “poor understanding” group and also reported higher 
average self-care scores in the preceding 7 days than the “poor understanding” group  
(p. 9).   
In a similar study conducted in Trinidad and Tobago (Ezenwaka et al., 2014), 89 
diabetic patients who knew nothing about A1C testing were tested for their knowledge of 
laboratory testing for monitoring glucose.  These subjects were then randomly selected to 
participate in a study in which the objective was determine the difference in congenital 
heart disease risk between diabetic women who were provided with facilities for self-
monitoring of blood glucose (intervention group) and diabetic women who were not 
provided the same facilities (control group).  Women in the intervention group had 
significantly lower levels of A1C after 3 months than women in the control group 
(Ezenwaka et al., 2014).  The researchers concluded that providing diabetic patients with 
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facilities to self-monitor blood glucose improved blood glucose levels and the congenital 
heart disease risk profile (Ezenwaka et al., 2014).   
Nurse-Led Interventions and Diabetes Management 
 Nurses can use a number of interventions to assist patients with diabetes in 
improving blood glucose levels.  Diabetes self-management and training programs (many 
times conducted by nurses) have demonstrated improved clinical and psychosocial 
outcomes for participants (Cook-Johnson, Parker, Clifton, Shams, & Young, 2012; 
Houweling et al. 2011; Massimi et al. 2017).  Nurses also provide instruction on 
interpretation of laboratory results, medical compliance, foot care, and other aspects of 
treatment, which all contribute to successful diabetes management.   
Cook-Johnson et al. (2012) identified additional information on the role nurses 
play in diabetes management.  In this review, the effects of nurse-led interventions on 
blood glucose levels and associated comorbidities were examined.  No evidence was 
found to suggest that nurse-led care improved Hgb A1C levels for patients with type 2 
diabetes.  However, evidence was found of significant improved outcomes, such as 
reduced blood pressure and LDL cholesterol levels (Cook-Johnson et al., 2012).   
Gaps in Literature 
 Gaps in the literature are evident related to a standardized protocol for Hgb A1C 
monitoring as a tool for diabetes management.  Although monitoring is respected as the 
gold standard for accurate monitoring of blood glucose levels and an essential component 
of effective diabetes management (Jones, 2013), the problem remains that currently no 
standardized protocol exists for how monitoring is used.  The literature supports diabetes 
patient knowledge of the Hgb A1C test and laboratory testing for blood glucose as 
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improving their self-management and A1C levels (Heisler, 2005; Yang et al. 2014).  
However, despite such support, there are no systematic literature reviews for this 
monitoring tool for diabetes management.   
Possible Reasons Why Hgb A1C May Not Be Used 
Diagnostic criteria for Hgb A1C must be validated and conducted through a 
standardized procedure approved by the National Glycohemoglobin Standardization 
Program3 (Malkani & Mordes, 2011).  Test results can be 0.5% lower or higher 
compared to a real percentage; a value of 7.0% Hgb A1C can be actually between ~6.5 
and 7.5% (NIDDK, 2014).   In addition, experts have cautioned about misleading results 
if the test is conducted on people with coexisting hemolytic anemia, iron deficiency, 
hemoglobinopathies, renal ailments, and/or acute hepatic (Goldenberg & Punthakee, 
2013).  Despite these cautions, Hgb A1C monitoring should be initiated as a standard of 
care.  Notice can be given for people who are suffering from other ailments, and the Hgb 
A1C values obtained can be considered in diagnosis (Jones, 2013). 
Summary 
 A guide that employs the use of Hgb A1C monitoring to manage diabetes and 
improve glycemic control continues to be necessary as diabetes becomes more prevalent.  
Such a guide is an easy, cost-effective way to achieve diabetes management goals where 
healthcare resources are limited.  Hgb A1C testing to pinpoint blood glucose levels more 
precisely than other forms of glucose testing is highly effective and considered the gold 
standard, not only for diagnosis of diabetes but also for POCT and self-management.  
With Hgb A1C monitoring, clinicians will discover, in real time, the status of 
patient blood glucose levels.  Healthcare providers may then immediately modify 
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treatments and institute interventions, thereby reducing the devastating effects of 
comorbidities which may develop due to damage of the microvascular and macrovascular 
systems of the body.  The current lack of a standardized protocol of Hgb A1C monitoring 
for diabetes management emphasizes the need for such a protocol.   
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Chapter 3 
Methods 
This chapter explains the methodology used to implement this DNP project.  The 
methods were subdivided to address the focus and purpose of the project.  The chapter 
provides information related to project design and the activities for subject selection and 
recruitment, in addition to how data were collected, managed, and analyzed; determine 
retrospectively the healthcare providers’ ordering, monitoring, and follow-up 
appointments for adult diabetic patients with abnormal Hgb A1Cs; to develop and 
implement a standardized process for healthcare providers to monitor and follow these 
patients, especially those with possible non-clinical follow-up compliance and abnormal 
Hgb A1C; to determine prospectively healthcare providers’ ordering, monitoring, and 
follow-up appointments; and to evaluate the prospective charts to determine if Hgb AIC 
results changed from abnormal to normal or elevation over time until the next follow-up 
appointment.    
Approximately 75% of the diabetic patients at the primary care center attended 
clinic appointments and showed an improvement in blood glucose levels after the 
standardized guide was implemented. The investigator compared one dependent variable, 
Hgb A1C, to two independent variables that monitored Hgb A1C levels and clinic 
follow-ups prior to and following a standardized guideline for providers’ implementation.
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Project Design 
To evaluate the quality improvement project, two data analysis methods were 
used: (a) a frequency test to determine appointment adherence retrospectively and 
prospectively; and (b) a nonparametric quantitative paired t test (two-tailed) to monitor 
patients diagnosed with poorly controlled diabetes who were treated in the clinic over the 
course of the 3-month time spans between March 1 through May 31, 2017, and June 1 
through August 31, 2017.  This approach was selected because the data were readily 
available, practical in terms of cost and time expended, and allowed for the collection of 
data from a relatively large number of cases.    
Setting 
The project took place at a family practice primary care clinic located in 
Brooklyn, New York.  The clinic serves a multicultural population of low-income, high- 
risk chronic disease individuals, especially those with diabetes.  Approximately 80% of 
the patients have been diagnosed with diabetes. 
Population and Sample Selection 
The project population consisted of two groups. Group 1 was comprised of with 
various levels of healthcare providers (N = 7), such as MD, APRN, RN, diabetic 
educator, nutritionist, and receptionist, with 5 or more years of diabetic experience and 
average age of 45. Group 2 was comprised of diabetic patients with abnormal Hbg A1C 
levels and inconsistent follow-up appointments ordered and monitored by providers (N = 
99). The patients’ records were reviewed retrospectively and prospectively. 
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Sampling Strategy and Determination of Sample Size 
  A convenience sample of healthcare providers and medical records that met the 
inclusion criteria was used in the QI.  A priori calculation of sample size for the medical 
records was carried out with G*Power (Heinrich-Heine-Universität Düsseldorf, 2014) for 
dependent t test analysis.  With input parameters of a two-tailed test, alpha = 0.05, power 
= 0.80, and an anticipated medium effect size, d = 0.05, the required sample size was a 
total of 99 records.   
Inclusion Criteria  
The inclusion criteria for this project for the first group was that the healthcare 
providers had to be MDs, APRNs, RNs, or similar licensed providers; and had to be 
employed for at least 4 weeks at the primary care center and render diabetic services.  
The inclusion for the second group was that the electronic medical records (retrospective 
and prospective) had to be of diabetic patients with abnormal Hgb A1C and inconsistent 
clinic follow-up appointments between March 1 through August 31, 2017, who were seen 
by the healthcare providers at the center.  
Exclusion Criteria 
 The exclusion criteria for the first group applied to all healthcare providers who 
did not work for the primary care center in diabetic services and who worked less than 4 
weeks at the center.  The exclusion criteria for the second group was the electronic 
medical records of patients with normal Hgb A1C and consistent clinic follow-up 
appointments, as well as these characteristics for dates other than March 1 through 
August 31, 2017.  
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Ethical Considerations 
 This quality improvement project was reviewed by the Institutional Review Board 
(IRB) of Nova Southeastern University (NSU) and the human subjects’ rights board at 
the primary care center where the project was conducted.  A letter of exemption was 
granted by the NSU IRB (Appendix A) because human subjects were not used in the 
project implementation. A letter of support was provided by the primary care center 
(Appendix B).  
Project Phases/Objectives 
This project was structured to meet the following objectives:  
Objective 1: Conduct a retrospective electronic medical record review of adult 
diabetic patients with abnormal Hgb A1Cs who failed to return for follow-up 
appointments between March and May 2017.  
This objective was accomplished by a review of adult diabetic patients’ electronic 
medical records (N = 99) with abnormal Hgb A1C and inconsistent follow-up clinic 
appointments between March 1 and May 31, 2017.  The investigator conducted a 
frequency test to determine consistency. 
Objective 2: Develop and implement a standardized process for healthcare 
providers to closely monitor and follow adult diabetic patients especially those with 
possible nonclinic follow-up compliance and abnormal Hgb A1C. 
This objective was completed by incorporation of the CDC (2016) standardized 
diabetic management guideline to enhance providers’ consistency with ordering and 
monitoring diabetic patients’ Hgb A1C and follow-up clinic appointments.  
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  Phase 1: A standardized diabetic guideline was developed to include the 
CDC (2016) standards for improving healthcare delivery and healthcare outcomes 
associated with Hgb A1C normalcy and follow-up consistency (Appendix C). 
Phase 2: The standardized diabetic guideline was announced to the 
healthcare providers (Appendix D) and presented and implemented at the primary care 
center to increase diabetic management knowledge affiliated with ordering and 
monitoring Hgb A1C and clinical follow-up. 
Objective 3: Conduct a prospective electronic medical record review of  
the same retrospective adult diabetic patients whose Hgb A1C was ordered and 
monitored between June 1 and August 31, 2017. 
This objective was completed in two steps: 
Step 1: EMRs (N = 99) were prospectively reviewed to determine if 
providers ordered and monitored Hgb A1C in conjunction with the implemented 
standardized diabetic guideline. 
Step 2: EMRs (N = 99) were prospectively reviewed to  
determine if diabetic patients were consistent or inconsistent with clinic follow-up 
appointments. This step was accomplished by the investigator conducting a frequency 
test to determine prospectively if clinic appointments demonstrated consistency or not. 
Objective 4: Evaluate the EMR charts prospectively to determine if the diabetic 
patients’ Hgb AIC results in changes from abnormal to normal or elevation over time 
until the next follow-up appointment.    
This objective was accomplished by review of the electronic medical records  (N 
= 99) prospectively between June 1 and August 31, 2017, to determine clinic 
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appointment consistency and Hgb A1C normalcy.  The investigator conducted a 
frequency test to determine appointment consistency and a nonparametric paired t test to 
determine Hgb A1C normalcy.  
Timeline 
The project took place over 16 weeks. Objective 1 was completed at the end of 
Week 1.  Objective 2 was completed by the end of Week 3, including both the 
development and implementation phases of the standardized guideline. Objective 3 was 
completed by the end of Week 12, and Objective 4 was completed by the end of Week 
16, including project phases and data analysis. 
Resources/Budget 
The project costs included an educational session that incorporated CDC (2016) 
standardized recommendations for diabetic management and diagnostic monitoring. 
Tokens of appreciation were given to all healthcare providers who participated in the 
project (N = 7).  The total cost for the project was $310.  Table 1 displays all itemized 
costs.   
Summary 
This chapter described the project methods. The purpose of the project was to 
determine retrospectively healthcare providers’ ordering, monitoring, and follow-up 
appointments for adult diabetic patients with abnormal Hgb A1Cs; develop and 
implement a standardized process for healthcare providers to monitor and follow these 
patients, especially those with possible nonclinic follow-up compliance and abnormal 
Hgb A1C.  
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Table 1  
 
Project Resources and Budget 
 
 
Category 
 
Item  
 
   Description 
 
Quantity 
 
Total 
 
 
Printing 
Services 
 
  Paper, ink, and   
  custom printing   
  and binding 
 
     
Guidelines for 
intraprofessional 
team and staff  
 
15 
 
$20.00 
Staff 
Appreciation 
   Luncheon 
 
 
   Appreciation   
   token for staff 
Intraprofessional 
team and staff 
 
Gift card  
 
$10.00 x 15 
 
 
$20.00 x 7            
 
 
$150.00 
 
 
$140.00 
 
Total Costs 
 
 
   
$ 310.00 
 
 
Additionally, the purpose was to determine prospectively healthcare providers’ 
ordering, monitoring, and follow-up appointments; and evaluate the prospective charts to 
determine if Hgb AIC results changed from abnormal to normal or elevation until the 
next follow-up appointment.  At a family practice primary care clinic in Brooklyn, New 
York, two groups were utilized: healthcare providers with experience treating diabetics 
(N = 7) and diabetic patients (N = 99).  
Frequency tests were used to determine appointment adherence retrospectively 
and prospectively. A nonparametric quantitative paired t test was used to measure 
patients diagnosed with poorly controlled diabetes who were treated over two 3-month 
timespans. Ethical considerations were met: The IRB of Nova Southeastern University 
provided a letter of exemption because human subjects were not involved in project 
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implementation (Appendix A), and the primary care center provided a letter of support 
(Appendix B). The project was completed with four objectives and several steps.
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Chapter 4 
Results and Discussion 
In accordance with the CDC (2016) recommendations, providers managing 
diabetic patients with standardized practice and best healthcare delivery systems can 
positively influence health outcomes.  This quality improvement project reviewed adult 
diabetic patient’s electronic medical records at two different periods, retrospectively and 
prospectively, to determine if healthcare providers ordered and monitored Hgb A1C and 
follow-up clinic appointments in accordance with standardized practice and whether 
patients improved.   
Outcome Measures 
Data Analysis Procedures 
To ensure that the data were entered without error, a frequency table was 
generated to detect the margin of error + -5 values.  When accuracy of data entry had 
been determined, the data were evaluated for outlying scores, defined as extreme 
individual scores that were at least three standard deviations above or below the mean  of 
the group.  These scores were detected by use of frequency distribution and box plots.  
Extreme scores were identified and retained.  
34 
 
 
Descriptive statistics were used to describe the sample and report the measures of 
central tendency of the variables.  First, demographic information was analyzed and 
reported with frequencies and percentages.  Then, a two-tailed paired t test was used to 
compare the retrospective and prospective scores.  The results for the dependent variable 
healthcare providers’ reports, were reported as measures of central tendency.  Histograms 
for the distribution of scores for the dependent variable and the Kolmogorov-Smirnov (K-
S) statistic were explored to assure the data met the assumption of normal distribution 
necessary for parametric testing.  Levene’s test was used to test of the assumption of 
homogeneity of variance.   
Patients’ Demographic Characteristics 
Descriptive statistics were collected for patients’ demographic characteristics 
related to diabetes.  These were patients’ ages at the time of data collection, ages at 
diagnoses of diabetes, and number of years living with diabetes. Table 2 illustrates the 
results.  
The age range of the 99 patients at review varied from 17 to 83, with the median 
age 60; half the patients (50%) were above the age of 60.  Three-quarters (75%) of the 
patients were above the age of 41.  
The age at which diabetes was diagnosed ranged from 12 to 82, with the median 
age 47; half of the patients were diagnosed after reaching the age of 47. Three-quarters of 
the patients were diagnosed after reaching the age of 36. 
The number of years patients were living with diabetes ranged from 0 (less than 1 
year) to 28 years. The median years living with diabetes was 11; half of the patients had 
been living with diabetes for more than 11 years.  
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Table 2  
 
Patients’ Demographic Characteristics (N = 99) 
 
 
 
Value 
 
 
Patients’ Age 
 
 
Age Diagnosed 
 
Years Living With 
Diabetes 
 
 
Median 
 
 
60 
 
47 
 
11 
Range 66 70 28 
Minimum 17 12  0 
Maximum 83 82 28 
25th Percentile 41 36  5 
50th Percentile 60 47 11 
75th Percentile 71 60 15 
 
 
Outcome Variable 
 
One outcome variable, Hgb A1C, for adult diabetic patients was measured and 
compared at two different periods: March 1 through May 31, 2017; and June 1 through 
August 31, 2017.  The first period took place prior to the implementation of standardized 
practice for healthcare providers at the primary care center.  The 3-month chart review of 
the EMR revealed an insufficiency in care standardization and healthcare provider 
follow-up for Hgb A1C and clinic appointments. The Hgb A1C test results are reported 
as percentages (Table 3).   
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Table 3 
A1C Results, Retrospective: March 1-May 31, 2017 (N = 99) 
 
Value 
 
Patients’ Age 
 
Age Diagnosed 
 
 
A1C 
 
Median  
 
 
60 
 
47 
 
 
A1C Range  66 70 6 
A1C Minimum 17 12 7 
AlC Maximum 83 82              13 
A1C Mean                  8.17 
Standard Deviation       1.33 
25th Percentile 41.00 36.00     8.00 
50th Percentile 60.00 47.00     9.00 
75th Percentile 71.00 60.00   10.00 
 
 
For the retrospective period March 1 through May 31, 2017, the A1C scores for 
99 patients were recorded and ranged between 7 and 13 with an average of 8.17.  Half of 
the patients’ A1Cs were above 9, with three-quarters above 8. The data collected from the 
EMR were exported to an Excel spreadsheet and transferred to SPSS for analysis.  Data 
analysis procedures followed Field’s (2009) guidelines.   
 The second period took place following the implementation of standardized 
practice for healthcare providers at the primary care center.  All 99 patients were given 
appointment dates for 3 months following their visits between March and May.  The A1C 
scores for 62 of the 99 patients were recorded during the 3-month period of June 1 to 
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August 31, 2017, and 62.6% kept the appointments.  The Hgb A1C test results are 
reported as percentages (Table 4).   
Table 4 
 
A1C Results, Prospective: June 1-August 31, 2017 (N =62)  
 
 
Value 
 
Patients’ Age 
 
Age Diagnosed 
 
 
A1C 
 
Median  
 
 
60 
 
47 
 
 
A1C Range  66 70   5.50 
A1C Minimum 17 12   6.50 
AlC Maximum 83 82             12.00 
A1C Mean                 9.28 
Standard Deviation     1.03 
25th Percentile 41.00 36.00   7.50 
50th Percentile 60.00 47.00   8.00 
75th Percentile 71.00 60.00   9.00 
 
 
For the prospective period June 1 to August 31, 2017, the patients’ A1C scores 
ranged between 6.5 and 12, with an average of 9.28. Half of the patients had A1C above 
8; three-quarters had A1C above 7.5. The decrease in AlC levels indicated greater 
providers’ utilization and patients’ adherence to the recommended guidelines, and the 
increase in follow-up appointments indicated enhanced care continuity.  
Testing the Data 
In this quality improvement project, the investigator sought to determine if there 
was a difference in one dependent variable, Hgb A1C, measured at two points in time, 
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prior to and after the implementation of the standardized CDC guideline for healthcare 
providers’ utilization for diabetic management and practice.  The Hgb A1C was 
measured as continuous level data.  The nonparametric t test was used to compare the 
electronic medical records retrospectively and prospectively of the same diabetic patients 
to determine if healthcare providers ordered and monitored Hgb A1C and clinic follow-
up appointment with consistency. The prospective EMR review reflected healthcare 
providers’ insufficiency in ordering and monitoring Hgb A1C between March 1 and May 
31, 2017.  Thus, a paired t test was used to determine the clinical practice outcome. The 
results were considered statistically significant with a probability value (p) of less than 
0.05.   
Differences in Scores 
 The differences in A1C scores between the two 3-month period was calculated 
from the EMR.  Only scores for patients who attended the follow-up appointments were 
used.  The total retrospective EMR reviewed were 135.  However, 99 EMR met inclusion 
criteria between March 1 and May 31, 2017, which served as the project benchmark for 
CDC (2016) 3-month standards until normalcy and clinic follow-up appointment 
consistency.   
 Table 5 illustrates the differences in Hgb A1C scores.  As the table shows, 29% 
showed no A1C improvement even with the healthcare providers ordering and 
monitoring. However, 71% of the follow-up patients’ Hgb A1C scores improved in the 
June to August period when compared to their previous scores of the March to May 
period.  The differences in Hgb A1C scores ranged from -4.5 to 2, with an average 
improvement in A1C score of -1.32.   
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Table 5 
Differences in Hgb AlC Scores Retrospectively and Prospectively  
 
 Of the 99 prospectively reviewed EMR between June 1 and August 31, 2017, 
37 patients did not keep their follow-up appointments, and 66 patients kept their follow-
up appointments, for a response rate of 63%.  This percentage reflected an improvement 
in healthcare providers’ ordering and monitoring  
of Hgb A1C after implementation of the CDC standardized guideline. Table 6 illustrates 
the differences in consistency of follow-up appointments. 
 
 
 
Value 
 
Mar-May A1C 
 
June-Aug A1C 
 
Difference 
 
 
Valid N 
 
99 
 
62 
 
62 
 
Missing N  0 37 37 
Range  6.0  5.5 6.5 
Minimum  7.0  6.5             -4.5 
Maximum                13.0 12.0  2.0   
Mean    9.28     8.17             -1.32 
Standard 
Deviation 
   1.33     1.03  1.35 
25th Percentile    8.00    7.50 -2.00 
50th Percentile    9.00    8.00 -1.00 
75th Percentile 
 
10.00    9.00   0.00 
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Table 6 
 
Differences in Follow-Up Appointments Retrospectively and Prospectively  
 
Difference 
 
 
Frequency 
 
Percent 
 
Valid Percent 
 
Improved 
 
44 
 
 44.4 
 
 71.0 
 
Did Not Improve 
 
81 
 
 18.2 
 
 29.0 
 
Total 
 
62 
 
 62.6 
 
100.0 
 
Missing 
 
37 
 
 37.4 
 
 
Total 
 
99 
 
100.0 
 
 
 
Test for Significance 
 
 To test for significant differences between the two periods, a Wilcoxon Signed 
Rank Test (paired nonparametric t test) was conducted.  Tables 7 and 8 illustrate the 
results. The p value was 0.00, which is less than the declared 0.05 p value.  The p of 0.00 
found showed that the difference is A1C scores of patients who attended their follow-up 
appointments was significant.  Thus, it can be concluded that the difference in scores was 
associated with the intervention of the second 3-month period.  
  
42 
 
 
Table 7 
Wilcoxon Signed Ranks Test for Significance: March-May and June-August 
 
Ranks 
 
N 
 
Mean Rank 
 
Sum of Ranks  
 
 
Negative Ranks 
 
 
2
a 
 
19.50 
 
39.00 
Positive Ranks 44
b 
23.68 1042.00 
 
Ties 
 
16
c 
  
 
Total 
 
62 
 
 
 
 
 
 
a
Mar-May A1C < Jun-Aug A1C. 
b
Mar-May A1C > Jun-Aug A1C. 
c
Mar-May A1C = Jun-Aug A1C. 
 
Table 8 
 
Nonparametric Analysis 
 
  
Mar-May A1C – Jun-Aug A1C 
 
 
Z 
 
 -5.512
a 
 
Asymp. Sig. (2-tailed) 
 
 
  0.00* 
 
 
a 
Based on negative ranks. 
*p < .05. 
 
Discussion 
 The project results indicated success in the use of a standardized guideline for 
healthcare providers’ monitoring A1C scores of patients.  Hgb A1C scores went down for 
a significant number of patients with healthcare providers ordering and monitoring.  The 
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providers’ frequency of ordering and monitoring Hgb A1C and follow-up appointments 
improved. Based on the improvement of patients’ A1C levels, the healthcare providers 
increased their ordering, monitoring, and follow-ups. 
Limitations 
 Several limitations are acknowledged for this project. The data were collected at 
only one facility, and therefore the results cannot be generalized to a more global 
environment.  The samples of the employees and EMR were not randomly selected, 
further limiting generalizability to similar conditions. Further, the implementation took 
place at a single point in time, lacking a longitudinal component for practice engagement. 
This limitation may have influenced providers’ healthcare delivery and patients’ 
healthcare outcomes.   
Additionally, although healthcare providers’ careful surveillance of Hgb A1C 
ordering and monitoring was investigated, other factors that influenced Hgb A1C results 
and clinic follow-up appointment consistency were not considered.  These factors may 
have included the healthcare professionals’ actual experiences with diabetic patients and 
accuracy of chart notations. Possibly also some healthcare providers ordering and 
monitoring may have been influenced by the investigator’s clinical presence, which 
reminded providers to implement CDC standards and recommendations. The 
investigator’s presence may have precipitated the Hawthorne effect (Goodwin et al., 
2017), in which providers may have changed their behavior knowing they were being 
observed. This effect is not a new phenomenology, but can change the outcome of 
observed behaviors.    
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Strengths 
 Project strengths included the extended body of knowledge surveyed for 
healthcare providers, especially for nurses to incorporate standardized guidelines for care 
consistency at diabetic care clinic. The project’s success also established a foundation for 
future clinic change through the utilization of theory and practice specifically for chronic 
diseases such as diabetes. The knowledge and results of this project can benefit future 
research and policy adaptability and feasibility for change in evidence-based practice.  
The changes apply especially to healthcare outcomes for Hgb A1C ordering, monitoring, 
and clinic follow-up appointments managed by healthcare providers in all areas of 
specializations.  
Conclusion   
 Diabetes mellitus is a chronic disease for which there is no cure (NIDDK, 2016).  
A major option is management (NIDDK, 2016).  Healthcare providers associated with 
this DNP project, including nurse practitioners, incorporated standardized practice for 
ordering and monitoring diabetic patients after the implementation of CDC (2014) 
standardized recommendations and guideline. A retrospective electronic medical records 
review revealed that healthcare providers were inconsistent in care management related 
to the ordering and monitoring for diabetic patients with abnormal Hgb A1C and 
inconsistent clinic appointment follow-ups. However, after intervention, both the Hgb 
A1C levels and appointment follow-ups improved.  
The lack of appropriate healthcare provider management of diabetic patients can 
lead to other healthcare complications.  The monitoring of patients for Hgb A1C levels 
with a prospective chart review was a simple yet viable approach that assisted healthcare 
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practitioner with helping patients to achieve blood glucose normalcy and clinic 
appointment follow-up consistency after the implementation of standardized practice.  
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Appendix A 
Nova Southeastern University Institutional Review Board Letter of Exemption
  
  
NOVA SOUTHEASTERN UNIVERSITY
Institutional Review Board 
3301 College Avenue • Fort Lauderdale, Florida 33314-7796
(954) 262-0000 • 800-672-7223, ext. 5369 • Email: irb@nova.edu • Web site: www.nova.edu/irb 
MEMORANDUM
To: Jacqueline Nugent
From: Vanessa Johnson, 
Center Representative, Institutional Review Board
Date: June 28, 2017
Re: IRB #:  2017-416; Title, “Monitoring Abnormal A1C Follow Up Appointments: A Nurse 
Practitioner Perspective”
I have reviewed the above-referenced research protocol at the center level.  Based on the information 
provided, I have determined that this study is exempt from further IRB review under 45 CFR 46.101(b) ( 
Exempt Category 4).  You may proceed with your study as described to the IRB.  As principal 
investigator, you must adhere to the following requirements:
1) CONSENT:  If recruitment procedures include consent forms, they must be obtained in such a 
manner that they are clearly understood by the subjects and the process affords subjects the 
opportunity to ask questions, obtain detailed answers from those directly involved in the research, 
and have sufficient time to consider their participation after they have been provided this 
information.  The subjects must be given a copy of the signed consent document, and a copy 
must be placed in a secure file separate from de-identified participant information.  Record of 
informed consent must be retained for a minimum of three years from the conclusion of the study.
2) ADVERSE EVENTS/UNANTICIPATED PROBLEMS:  The principal investigator is required to 
notify the IRB chair and me (954-262-5369 and Vanessa Johnson, respectively) of any adverse 
reactions or unanticipated events that may develop as a result of this study.  Reactions or events 
may include, but are not limited to, injury, depression as a result of participation in the study, life-
threatening situation, death, or loss of confidentiality/anonymity of subject.  Approval may be 
withdrawn if the problem is serious.
3) AMENDMENTS:  Any changes in the study (e.g., procedures, number or types of subjects, 
consent forms, investigators, etc.) must be approved by the IRB prior to implementation.  Please 
be advised that changes in a study may require further review depending on the nature of the 
change.  Please contact me with any questions regarding amendments or changes to your study.
The NSU IRB is in compliance with the requirements for the protection of human subjects prescribed in 
Part 46 of Title 45 of the Code of Federal Regulations (45 CFR 46) revised June 18, 1991.
Cc: Mary D Mites-Campbell, PhD
Vanessa Johnson
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Appendix C 
Standardized Guide 
 
MEDICAL URGENT PC- FAMILY PRACTICE 
 
POLICY/PROCEDURE 
 
Subject:  Monitoring abnormal A1C follow-up appointment 
 
Effective Date: 3/3/2017 Revision Date: Supers 
cedes: 
 
Distribution:  MD, DO, PA, APRN, RN 
 
PURPOSE:  
To insure healthcare provider’s incorporate CDC standards for ordering 
and monitoring adult diabetic patients Hgb A1C and clinic follow-up 
consistency.  
      
POLICY:  
Providers delivering care to adults diagnosed or at risk for diabetes must 
incorporate CDC standardized practice for ordering and monitoring Hgb 
A1C for both care continuity at clinic follow-up and self-management. The 
provider: 
 
 Order and monitor abnormal Hgb A1C quarterly or frequently 
depending on the non-normalcy results. 
 Help educate ways to reduce elevated Hgb A1C levels. 
 Minimize patients’ risk for abnormalcy by incorporating 
assessment, interventions, and surveillance.  
 Community-based team interaction with primary care providers, 
pharmacist, dietitian, case managers, and educators to help 
improve patient’s weight loss and A1C values. 
 Integrate the three key objectives for care delivery: (1) optimize 
provider and team behavior; (2) support patient behavior change; 
& (3) change the system of care, especially to include ordering, 
monitoring, and clinic follow-up appointment consistency. 
 Direct care in a timely manner based on evidence-based guidelines. 
 Make sure the care model is based on a patient-centric approach 
that guides care consistency. 
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  Documentation and Limitations 
 
 All A1C management steps will be maintained through standardization 
competency.   
 At the end of the clinical visit, the provider will distribute “The 
Diabetes Education Program – Understand Your A1C” brochure with 
cultural reflective insight for patient understanding and adherence; the 
documentation system or record will include cultural awareness 
language that drove patient’s compliance; and at a minimum the 
provider should provide cultural references that incorporate 
standardize evidence-based practice.   
 A follow-up process should be implemented by the provider that 
identify the patient’s name, cultural preference, and/or identifier for 
enhancing care competence and treatment standardization.   
 Educate staff regarding patient follow-up processes through the use of 
a standardized monitoring system. 
 Consider conducting periodic chart review to evaluate the 
effectiveness of the established process for patient, case management 
driven. 
 Staff should assess the clinical important of the appointment, the 
severity of the patient medical condition, and the risk(s) associated 
with the missed appointment to determine appropriate follow-up 
 Develop a process for the follow-up of patients who have missed 
appointments. 
 
The appropriate skills providers must be present for the use for  
A1C Management  
 
 Provide a delivery services that include respect, health belief practices 
and linguistic needs of diver for patients. 
 Integrate Diabetes Care Standards and principles for the care of person 
with or at risk for diabetes elevated or lower A1C 
 Assess a patient’s communication skills and belief systems prior to 
developing a treatment plan 
 
PROCEDURE: 
 
 Initial Assessment 
o Include cultural norms and ethical practices in conjunction with regulatory 
standards 
 
 Monitor microalbumin as per standardized protocol 
 
 Testing will be done as specified by regulatory standards implemented through 
the protocol:  
a. Annually for anyone diagnosed with prediabetes. 
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b. Twice a year for individuals with type 2 diabetes who do not use insulin and 
whose diabetes is within the goal set by their doctor. 
c. Three to four times annually for individuals with type 1 diabetes. 
d. Four times yearly for individuals with type 2 diabetes who use insulin and 
whose condition is not under control 
 Patients will be disease managed especially those who have missed more than one 
appointment. A letter will be mail to remind them of a rescheduled follow-up 
visit.  
 A patient-family centered care approach that provides information on diabetes, 
treatment rationale, importance of medical follow-up, and how to incorporate 
and/or avoid certain cultural meals that can reduce diabetic-related conditions but 
enhance quality of life and well-being.   
 
RESOURCES: 
 
Healthcare providers will include various educational resources. For patient-family 
best disease prevention, health maintenance, and quality of life sustainability; two-
three resources will be provided.  Resources will be provide based on patient/family 
social determinants: living environment; economic sustainability; age; educational 
level, etc.  
 
 American Academy of Family Physicians: Management of Newly Diagnosed 
Type 2 Diabetes Mellitus in Children and AdolescentsExternal Link Disclaimer 
 The American Association of Clinical Endocrinologists: Clinical Practice 
GuidelinesExternal Link Disclaimer 
 American College of Physicians: Comparative Guideline Table: Screening for 
DiabetesExternal Link Disclaimer 
 American Diabetes Association: 2016 Standards of Medical Care in 
DiabetesExternal Link Disclaimer 
 American Heart Association: Diabetes MellitusExternal Link Disclaimer 
 The American Geriatrics Society: Guidelines for Improving the Care of Older 
Adults with Diabetes MellitusExternal Link Disclaimer 
 Endocrine Society: Clinical Practice GuidelinesExternal Link Disclaimer 
 National Committee for Quality Assurance: Diabetes Recognition 
ProgramExternal Link Disclaimer 
 U.S. Preventive Services Task Force: Published RecommendationsExternal Link 
Disclaimer 
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